今日の臨床サポート

溶血性貧血

関連論文:
img  3:  Guidelines for the diagnosis and management of hereditary spherocytosis.
 
著者: P H B Bolton-Maggs, R F Stevens, N J Dodd, G Lamont, P Tittensor, M-J King, General Haematology Task Force of the British Committee for Standards in Haematology
雑誌名: Br J Haematol. 2004 Aug;126(4):455-74. doi: 10.1111/j.1365-2141.2004.05052.x.
Abstract/Text Hereditary spherocytosis (HS) is a heterogeneous group of disorders with regard to clinical severity, protein defects and mode of inheritance. It is relatively common in Caucasian populations; most affected individuals have mild or only moderate haemolysis. There is usually a family history, and a typical clinical and laboratory picture so that the diagnosis is often easily made without additional laboratory tests. Atypical cases may require measurement of erythrocyte membrane proteins to clarify the nature of the membrane disorder and in the absence of a family history, occasionally molecular genetic analysis will help to determine whether inheritance is recessive or non-dominant. It is particularly important to rule out stomatocytosis where splenectomy is contraindicated because of the thrombotic risk. Mild HS can be managed without folate supplements and does not require splenectomy. Moderately and severely affected individuals are likely to benefit from splenectomy, which should be performed after the age of 6 years and with appropriate counselling about the infection risk. In all cases careful dialogue between doctor, patient and the family is essential. Laparoscopic surgery, when performed by experienced surgeons, can result in a shorter hospital stay and less pain.

PMID 15287938  Br J Haematol. 2004 Aug;126(4):455-74. doi: 10.1111/j.1365-2141.2004.05052.x.
戻る

さらなるご利用にはご登録が必要です。

こちらよりご契約または優待日間無料トライアルお申込みをお願いします。

(※トライアルご登録は1名様につき、一度となります)


ご契約の場合はご招待された方だけのご優待特典があります。

以下の優待コードを入力いただくと、

契約期間が通常12ヵ月のところ、14ヵ月ご利用いただけます。

優待コード: (利用期限:まで)

ご契約はこちらから